Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Collegium Pharmaceutical
COLL
5
Enerpac Tool
EPAC
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | -0.07%1.73B | -1.18%384.38M | -0.43%545.9M | 0.32%497.59M | 1.39%297.42M | -0.27%1.73B | -0.40%388.97M | -3.00%548.25M | -1.74%496.03M | 8.37%293.35M |
Operating revenue | -0.07%1.73B | -1.18%384.38M | -0.43%545.9M | 0.32%497.59M | 1.39%297.42M | -0.27%1.73B | -0.40%388.97M | -3.00%548.25M | -1.74%496.03M | 8.37%293.35M |
Cost of revenue | -0.22%131.41M | -2.51%29.09M | 0.49%40.63M | 1.14%38.65M | -0.75%23.05M | -2.60%131.7M | 1.92%29.84M | -2.31%40.43M | -7.97%38.21M | 0.79%23.22M |
Gross profit | -0.06%1.59B | -1.07%355.3M | -0.50%505.27M | 0.25%458.95M | 1.57%274.38M | -0.07%1.59B | -0.59%359.13M | -3.06%507.82M | -1.18%457.82M | 9.07%270.13M |
Operating expense | -0.38%1.13B | 3.70%279.54M | -0.13%304.27M | -2.47%294.27M | -2.48%251.94M | 4.22%1.13B | 3.92%269.56M | -0.49%304.68M | 5.79%301.73M | 8.73%258.35M |
Selling and administrative expenses | -1.96%216.9M | 10.62%49.87M | -7.28%55.36M | -6.42%63.79M | -0.84%47.88M | 10.58%221.24M | 0.69%45.09M | 12.48%59.71M | 21.38%68.17M | 4.82%48.28M |
Depreciation amortization depletion | 5.99%163.44M | 6.50%42.4M | 6.14%41.58M | 6.48%40.28M | 4.78%39.18M | 1.04%154.21M | 4.11%39.81M | 5.25%39.17M | -1.87%37.83M | -3.15%37.39M |
-Depreciation and amortization | 5.99%163.44M | 6.50%42.4M | 6.14%41.58M | 6.48%40.28M | 4.78%39.18M | 1.04%154.21M | 4.11%39.81M | 5.25%39.17M | -1.87%37.83M | -3.15%37.39M |
Other operating expenses | -1.21%749.69M | 1.41%187.27M | 0.74%207.34M | -2.82%190.2M | -4.51%164.88M | 3.15%758.87M | 4.70%184.66M | -4.67%205.81M | 2.75%195.73M | 12.91%172.67M |
Operating profit | 0.72%463.87M | -15.42%75.76M | -1.05%201M | 5.50%164.68M | 90.51%22.43M | -9.27%460.57M | -12.07%89.57M | -6.66%203.13M | -12.35%156.09M | 17.09%11.78M |
Net non-operating interest income expense | -14.38%-167.76M | -37.67%-49.92M | -7.10%-39.68M | -6.58%-39.39M | -6.53%-38.78M | -24.82%-146.67M | -4.30%-36.26M | -21.26%-37.05M | -37.84%-36.95M | -43.48%-36.4M |
Non-operating interest expense | 14.38%167.76M | 37.67%49.92M | 7.10%39.68M | 6.58%39.39M | 6.53%38.78M | 24.82%146.67M | 4.30%36.26M | 21.26%37.05M | 37.84%36.95M | 43.48%36.4M |
Other net income (expense) | -473.93%-4.58M | -469.65%-1.46M | -126.25%-42K | -299.54%-2.6M | -846.00%-473K | -1,127.69%-798K | -314.52%-257K | 142.42%160K | -1,176.47%-651K | -177.78%-50K |
Special income (charges) | -453.43%-4.52M | -404.07%-1.49M | -91.37%12K | -318.90%-2.75M | -7,225.00%-293K | -655.56%-816K | -6,000.00%-295K | --139K | -690.36%-656K | 86.67%-4K |
-Less:Restructuring and merger&acquisition | -29.29%577K | --0 | 91.37%-12K | -54.88%296K | 7,225.00%293K | 655.56%816K | 6,000.00%295K | ---139K | 690.36%656K | -86.67%4K |
-Less:Other special charges | --3.94M | --1.49M | ---- | --2.45M | ---- | ---- | ---- | ---- | ---- | ---- |
Other non- operating income (expenses) | -455.56%-64K | -39.47%23K | -357.14%-54K | 2,840.00%147K | -291.30%-180K | -58.14%18K | 156.72%38K | -68.18%21K | -84.38%5K | -483.33%-46K |
Income before tax | -6.89%291.53M | -54.06%24.38M | -2.99%161.27M | 3.55%122.69M | 31.85%-16.82M | -19.73%313.11M | -20.86%53.05M | -11.17%166.24M | -21.65%118.49M | -60.95%-24.68M |
Income tax | -18.86%64.03M | -127.09%-3.52M | -2.55%41.6M | 0.43%31.57M | 31.59%-5.62M | -20.20%78.91M | -27.88%13M | -18.82%42.69M | -9.21%31.43M | -29.38%-8.21M |
Net income | -2.86%227.5M | -30.35%27.9M | -3.14%119.68M | 4.67%91.12M | 31.98%-11.2M | -19.57%234.2M | -18.28%40.05M | -8.18%123.56M | -25.35%87.06M | -83.23%-16.47M |
Net income continuous Operations | -2.86%227.5M | -30.35%27.9M | -3.14%119.68M | 4.67%91.12M | 31.98%-11.2M | -19.57%234.2M | -18.28%40.05M | -8.18%123.56M | -25.35%87.06M | -83.23%-16.47M |
Minority interest income | ||||||||||
Net income attributable to the parent company | -2.86%227.5M | -30.35%27.9M | -3.14%119.68M | 4.67%91.12M | 31.98%-11.2M | -19.57%234.2M | -18.28%40.05M | -8.18%123.56M | -25.35%87.06M | -83.23%-16.47M |
Preferred stock dividends | ||||||||||
Other preferred stock dividends | ||||||||||
Net income attributable to common stockholders | -2.86%227.5M | -30.35%27.9M | -3.14%119.68M | 4.67%91.12M | 31.98%-11.2M | -19.57%234.2M | -18.28%40.05M | -8.18%123.56M | -25.35%87.06M | -83.23%-16.47M |
Basic earnings per share | 4.37%3.82 | -17.74%0.51 | 8.29%2.09 | 8.09%1.47 | 34.62%-0.17 | -12.44%3.66 | -18.42%0.62 | -3.50%1.93 | -16.56%1.36 | -116.67%-0.26 |
Diluted earnings per share | 4.41%3.79 | -19.35%0.5 | 8.33%2.08 | 8.15%1.46 | 34.62%-0.17 | -12.32%3.63 | -18.42%0.62 | -3.52%1.92 | -16.67%1.35 | -116.67%-0.26 |
Dividend per share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | -- | -- | -- | -- | -- |